Legal advisor to the management of Julius Clinical on sale to Ampersand Capital Partners

Acted as legal advisor to the management of Julius Clinical Research in connection with the sale to Ampersand Capital Partners.

Julius Clinical is a contract research organization active in clinical research. The investment by Ampersand Capital Partners was intended to support further growth and international expansion, including in Europe and North America. Dealmaker lists the transaction as “Ampersand Capital Partners acquires Julius Clinical”, with a EUR 25–50 million transaction value category and a transaction date of 23 November 2023.

The legal work focused on the management position in the transaction, sale documentation, management participation and arrangements with the new investor. In private equity transactions involving management, the sale, reinvestment, governance and future management position need to be carefully aligned.

Need legal advice on a private equity transaction or management participation?

For questions about management participation, reinvestment, shareholder documentation or private equity transactions, please contact dirk.dewaard@viottalaw.com.

Deal highlights

Transaction type – Sale / private equity transaction / management participation

Client – Management of Julius Clinical Research

Buyer – Ampersand Capital Partners

Sector – Life sciences / clinical research / CRO

Role – Legal advisor to management

Legal work – Transaction documentation, management position, reinvestment, governance and private equity arrangements

Links
Dealmaker — Ampersand Capital Partners acquires Julius Clinical
Julius Clinical press release
PR Newswire

Related expertise

Private equity
Corporate / M&A
Shareholders agreement
Investment agreement
Commercial contracts

Involved lawyers.

If you need a legal opinion under Dutch law, please do not hesitate to contact us via
info@viottalaw.com or +31 20 248 06 00.

By VIOTTA.

Recent cases.

By VIOTTA.

More articles.

26 / 08 2026

Vesting After Year Four: Dead Equity and Dutch Startup Governance

Standard 4-year founder vesting can create problems when a startup takes longer to reach Series A or exit. This article explains how departing co-founders, dead equity, reverse vesting, leaver provisions, repurchase rights and cap table clean-up should be addressed in Dutch startup documentation.

READ ARTICLE
26 / 08 2026

Founder Refresh Equity in Later VC Rounds

Founder refresh equity can help keep key founders aligned after several successful financing rounds. This article explains when founders may receive new options, milestone equity, secondary liquidity or retention equity, and how these arrangements should be implemented in Dutch startup documentation.

READ ARTICLE
18 / 08 2026

Dutch vs US Share Purchase Agreements

US and Dutch share purchase agreements use many similar deal concepts, but the legal mechanics differ. This article compares representations and warranties, disclosure schedules, indemnities, escrows, caps, baskets, purchase-price adjustments, MAC/MAE clauses, interim covenants, restrictive covenants, governing law, corporate authority and Dutch notarial title transfer.

READ ARTICLE
18 / 08 2026

What Changes, and What Remains Dutch, After a Delaware Flip?

A Delaware flip moves investor governance and financing documentation to the Delaware parent, but many matters remain Dutch. This article explains what changes and what remains governed by Dutch law, including employment, contracts, IP ownership, board authority, corporate records and notarial actions.

READ ARTICLE
18 / 08 2026

Delaware Parent, Dutch Subsidiary

A Delaware parent can exercise shareholder control over a Dutch subsidiary, but the Dutch BV retains its own legal personality, management board, corporate records and Dutch-law decision-making requirements. This article explains parent control, board authority, reserved matters, signing authority and intercompany arrangements.

READ ARTICLE
18 / 08 2026

Delaware LLC vs Dutch BV

A Dutch BV is not the Dutch equivalent of a Delaware LLC. This article explains the key differences for US founders, investors and counsel, including ownership interests, contractual flexibility, management, legal personality, liability and transfer mechanics.

READ ARTICLE